150 related articles for article (PubMed ID: 32589198)
21. Correlation between Goldmann perimetry and maximal electroretinogram response in retinitis pigmentosa.
Iannaccone A; Rispoli E; Vingolo EM; Onori P; Steindl K; Rispoli D; Pannarale MR
Doc Ophthalmol; 1995; 90(2):129-42. PubMed ID: 7497885
[TBL] [Abstract][Full Text] [Related]
22. Chromatic Pupilloperimetry Measures Correlate With Visual Acuity and Visual Field Defects in Retinitis Pigmentosa Patients.
Sher I; Tucker Y; Gurevich M; Hamburg A; Bubis E; Kfir J; Zorani S; Derazne E; Skaat A; Rotenstreich Y
Transl Vis Sci Technol; 2020 Jul; 9(8):10. PubMed ID: 32855857
[TBL] [Abstract][Full Text] [Related]
23. Spatial Characteristics of Peripheral Visual Islands in Retinitis Pigmentosa.
Patel TP; Vongsachang H; Schilling A; Kong X; Singh MS
Invest Ophthalmol Vis Sci; 2022 Feb; 63(2):26. PubMed ID: 35175279
[TBL] [Abstract][Full Text] [Related]
24. Chromatic Multifocal Pupillometer for Objective Perimetry and Diagnosis of Patients with Retinitis Pigmentosa.
Chibel R; Sher I; Ben Ner D; Mhajna MO; Achiron A; Hajyahia S; Skaat A; Berchenko Y; Oberman B; Kalter-Leibovici O; Freedman L; Rotenstreich Y
Ophthalmology; 2016 Sep; 123(9):1898-911. PubMed ID: 27432203
[TBL] [Abstract][Full Text] [Related]
25. Long-term decline of central cone function in retinitis pigmentosa evaluated by focal electroretinogram.
Falsini B; Galli-Resta L; Fadda A; Ziccardi L; Piccardi M; Iarossi G; Resta G
Invest Ophthalmol Vis Sci; 2012 Nov; 53(12):7701-9. PubMed ID: 23111612
[TBL] [Abstract][Full Text] [Related]
26. Worse-than-usual visual fields measured in retinitis pigmentosa related to episodically decreased general health.
Bittner AK; Haythornthwaite JA; Diener-West M; Dagnelie G
Br J Ophthalmol; 2013 Feb; 97(2):145-8. PubMed ID: 23212205
[TBL] [Abstract][Full Text] [Related]
27. Effect of mydriasis on visual field area in retinitis pigmentosa.
Lam BL; Fishman GA; Anderson RJ; Smith DA; Alexander KR
Ophthalmology; 1992 Nov; 99(11):1724-7. PubMed ID: 1454349
[TBL] [Abstract][Full Text] [Related]
28. Correlation between macular blood flow and central visual sensitivity in retinitis pigmentosa.
Murakami Y; Ikeda Y; Akiyama M; Fujiwara K; Yoshida N; Nakatake S; Notomi S; Nabeshima T; Hisatomi T; Enaida H; Ishibashi T
Acta Ophthalmol; 2015 Dec; 93(8):e644-8. PubMed ID: 25688697
[TBL] [Abstract][Full Text] [Related]
29. Long-term follow-up of retinitis pigmentosa patients with multifocal electroretinography.
Nagy D; Schönfisch B; Zrenner E; Jägle H
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4664-71. PubMed ID: 18566474
[TBL] [Abstract][Full Text] [Related]
30. Correlation between aqueous flare and residual visual field area in retinitis pigmentosa.
Nishiguchi KM; Yokoyama Y; Kunikata H; Abe T; Nakazawa T
Br J Ophthalmol; 2019 Apr; 103(4):475-480. PubMed ID: 29858180
[TBL] [Abstract][Full Text] [Related]
31. Sector retinitis pigmentosa.
Van Woerkom C; Ferrucci S
Optometry; 2005 May; 76(5):309-17. PubMed ID: 15884421
[TBL] [Abstract][Full Text] [Related]
32. Wide-field fundus autofluorescence imaging of retinitis pigmentosa.
Oishi A; Ogino K; Makiyama Y; Nakagawa S; Kurimoto M; Yoshimura N
Ophthalmology; 2013 Sep; 120(9):1827-34. PubMed ID: 23631947
[TBL] [Abstract][Full Text] [Related]
33. Transcorneal Electrical Stimulation Dose-Dependently Slows the Visual Field Loss in Retinitis Pigmentosa.
Stett A; Schatz A; Gekeler F; Franklin J
Transl Vis Sci Technol; 2023 Feb; 12(2):29. PubMed ID: 36809335
[TBL] [Abstract][Full Text] [Related]
34. Progression of visual field loss in patients with retinitis pigmentosa of sporadic and autosomal recessive types.
Akeo K; Saga M; Hiida Y; Oguchi Y; Okisaka S
Ophthalmic Res; 1998; 30(1):11-22. PubMed ID: 9483583
[TBL] [Abstract][Full Text] [Related]
35. Kinetics of visual field loss in Usher syndrome Type II.
Iannaccone A; Kritchevsky SB; Ciccarelli ML; Tedesco SA; Macaluso C; Kimberling WJ; Somes GW
Invest Ophthalmol Vis Sci; 2004 Mar; 45(3):784-92. PubMed ID: 14985291
[TBL] [Abstract][Full Text] [Related]
36. Disease course of patients with pericentral retinitis pigmentosa.
Sandberg MA; Gaudio AR; Berson EL
Am J Ophthalmol; 2005 Jul; 140(1):100-6. PubMed ID: 15953579
[TBL] [Abstract][Full Text] [Related]
37. Progression of defects in the central 10-degree visual field of patients with retinitis pigmentosa and choroideremia.
Hirakawa H; Iijima H; Gohdo T; Imai M; Tsukahara S
Am J Ophthalmol; 1999 Apr; 127(4):436-42. PubMed ID: 10218696
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic potential of valproic acid for retinitis pigmentosa.
Clemson CM; Tzekov R; Krebs M; Checchi JM; Bigelow C; Kaushal S
Br J Ophthalmol; 2011 Jan; 95(1):89-93. PubMed ID: 20647559
[TBL] [Abstract][Full Text] [Related]
39. Visual acuity and visual field impairment in Usher syndrome.
Edwards A; Fishman GA; Anderson RJ; Grover S; Derlacki DJ
Arch Ophthalmol; 1998 Feb; 116(2):165-8. PubMed ID: 9488267
[TBL] [Abstract][Full Text] [Related]
40. Progression Rate of Visual Function and Affecting Factors at Different Stages of Retinitis Pigmentosa.
Ito N; Miura G; Shiko Y; Kawasaki Y; Baba T; Yamamoto S
Biomed Res Int; 2022; 2022():7204954. PubMed ID: 35872870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
